Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Irish vision to stem SCD (sudden cardiac death) in young - a global issue

This article was originally published in Clinica

Executive Summary

Ireland has announced groundbreaking plans to screen all people engaged in sport for sudden cardiac death (SCD), as part of a strategy to stem the relatively high incidence of the condition in the young. SCD (or sudden arrest) is not a heart attack (infarction), but involves the abrupt loss of heart function, often in cases that presented no symptoms of coronary heart disease (CHD).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT051089

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel